CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Asclemed USA Inc. recalls Duloxetine DR Capsules

Read the official FDA notice

Published
10 Jun 2026
Units affected
50 bottles
Agency
FDA
Country
United States

The hazard

CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc.

Brand / company
Asclemed USA Inc.
Codes / lots
Lot # 050725G-30 & 050725F-30, Exp Date: 06/30/2026
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 10 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.